Lecicarbon K Co2-Laxans Drei

Sodium Hydrogen Carbonate and Sodium Dihydrogen Phosphate, the active ingredient in Lecicarbon K Co2-Laxans Drei, is an osmotic laxative presented as a rectal formulation for rectal use. It helps relieve constipation and prepares the bowel for diagnostic procedures in adults.

GNH USA supplies Lecicarbon K Co2-Laxans Drei as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Lecicarbon K Co2-Laxans Drei, an osmotic laxative, is employed to manage conditions that require increased colonic water content. - Constipation: softens stool and promotes regular bowel movements. - Bowel preparation: facilitates cleansing of the colon before endoscopic or surgical procedures. - Pre‑operative bowel cleansing: aids in emptying the large intestine prior to surgery.

The following adverse reactions have been reported with rectal osmotic laxatives such as Lecicarbon K Co2-Laxans Drei.

Common Side Effects: - Abdominal cramping - Flatulence - Nausea - Mild diarrhea

Serious or Rare Side Effects: - Electrolyte imbalance (e.g., hypernatremia, phosphate disturbance) - Severe dehydration - Allergic reaction (rash, pruritus, angioedema) - Rectal bleeding

When using Lecicarbon K Co2-Laxans Drei, consider the following precautions. - Assess renal function: patients with severe renal impairment may be at risk of sodium accumulation. - Monitor electrolyte status: watch for potential hypernatremia or phosphate disturbances. - Use with caution in elderly: increased susceptibility to dehydration and electrolyte shifts. - Avoid in individuals with known hypersensitivity to sodium hydrogen carbonate or sodium dihydrogen phosphate. - Store at room temperature: keep in the original packaging, protect from moisture and direct heat.

Lecicarbon K Co2-Laxans Drei may interact with other medicines that affect electrolyte balance or sodium load.

Major Interactions (Avoid): - Concurrent high‑dose oral sodium phosphate solutions: risk of excessive phosphate load. - Co‑administration with loop or thiazide diuretics: may exacerbate electrolyte disturbances.

Moderate Interactions (Monitor Closely): - Use with antacids containing sodium: may increase overall sodium intake. - Combination with other laxatives of differing mechanisms: could cause excessive bowel stimulation. - Concomitant mineral supplements (e.g., calcium, magnesium): monitor phosphate and calcium levels.